Skip to main content

Table 1 Characteristics of diabetic patients versus non-diabetic patients, including serum lipid profile (Total cholesterol, LDL-Cholesterol, Triglycerides and HDL-Cholesterol levels), serum CRP levels, concomitant disease and drug therapy

From: A significant correlation between C - reactive protein levels in blood monocytes derived macrophages versus content in carotid atherosclerotic lesions

 

Diabetic patients (n = 10)

Non-diabetic patients (n = 10)

P value

Total Cholesterol (mg/dl)

163 ± 25

176 ± 30

N.S.

LDL (mg/dl)

94 ± 27

99 ± 26

N.S.

Triglycerides (mg/dl)

141 ± 40

142 ± 90

N.S.

HDL (mg/dl)

41 ± 10

50 ± 12

N.S.

hCRP (mg/dl)

5.2 ± 3.7

2.8 ± 1.8

0.1

Hemoglobin A1c level (%)

7.73

  

Mean Age (years)

67.3

67.7

N.S.

Females (%)

40

50

N.S.

Males (%)

60

50

N.S.

Hypertension (%)

90

90

N.S.

Hyperlipidemia (%)

100

80

N.S.

Smoking history (%)

60

45

N.S.

Ischemic heart disease (%)

60

60

N.S.

History of cerebrovascular disease (%)

50

40

N.S.

Known PVD (%)

30

20

N.S.

Aspirin/clopidogrel (% treated)

90

100

N.S.

Warfarin (% treated)

20

20

N.S.

Beta Blockers (% treated)

70

80

N.S.

Calcium Channel Blockers (% treated)

50

50

N.S.

Angiotensin receptors blockers/ACE-inhibitors (% treated)

50

70

N.S.

Statins (% treated)

100

90

N.S.

Hypoglycemic drugs (% treated)

90

0

<0.01

Symptomatic and asymptomatic patients (%)

30% symptomatic

30% symptomatic

N.S.

70% asymptomatic

70% asymptomatic

Time elapsed from diagnosis leading to endaterectomy (weeks)

5.9 ± 6.7

6.6 ± 7.8

N.S.

  1. (N.S.: non-significant).